Patents by Inventor Nianqing Xiao
Nianqing Xiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220170021Abstract: Methods and compositions are provided for oligonucleotide probes and oligonucleotide probe libraries that recognize targets of interest. The targets include circulating biomarkers such as microvesicles, including those derived from various diseases.Type: ApplicationFiled: April 9, 2021Publication date: June 2, 2022Inventors: Valeriy Domenyuk, Adam Stark, Nianqing Xiao, Zhenyu Zhong, Mark Miglarese, David Spetzler
-
Publication number: 20210382059Abstract: Methods and compositions are provided for specific aptamers and aptamer pools that bind biomarkers of interest such as microvesicle surface antigens or functional fragments of microvesicle surface antigens. In various embodiments, aptamers of the invention are used in diagnostic, prognostic, or theranostic processes to screen a biological sample for the presence or levels of biomarkers such as microvesicles that are determined to provide a diagnostic, prognostic, or theranostic readout. The diagnosis, prognosis, or theranosis may be related to cancer or other diseases and disorders. The invention also provides methods and composition to facilitate aptamer library screening and aptamer detection methods.Type: ApplicationFiled: December 21, 2020Publication date: December 9, 2021Inventors: David Halbert, Valeriy Domenyuk, David Spetzler, Tassilo Hornung, Frank Schäfer, Nianqing Xiao
-
Patent number: 10942184Abstract: Methods and compositions are provided for specific aptamers and aptamer pools that bind biomarkers of interest such as microvesicle surface antigens or functional fragments of microvesicle surface antigens. In various embodiments, aptamers of the invention are used in diagnostic, prognostic, or theranostic processes to screen a biological sample for the presence or levels of biomarkers such as microvesicles that are determined to provide a diagnostic, prognostic, or theranostic readout. The diagnosis, prognosis, or theranosis may be related to cancer or other diseases and disorders. The invention also provides methods and composition to facilitate aptamer library screening and aptamer detection methods.Type: GrantFiled: March 6, 2018Date of Patent: March 9, 2021Assignee: Caris Science, Inc.Inventors: David D. Halbert, Valeriy Domenyuk, David Spetzler, Tassilo Hornung, Frank Schafer, Nianqing Xiao
-
Publication number: 20210062270Abstract: Methods and compositions are provided for oligonucleotides that bind target biomarkers and allow characterization of a phenotype. The target biomarkers may include microvesicle antigens, including microvesicles derived from various diseases. The characterization may comprise detection, diagnosis, prognosis, theranosis or other characterization of a disease or disorder.Type: ApplicationFiled: July 23, 2020Publication date: March 4, 2021Inventors: David Spetzler, Valeriy Domenyuk, Nianqing Xiao, Adam Stark, Zhenyu Zhong
-
Publication number: 20200270610Abstract: Methods and compositions are provided for oligonucleotide probes and oligonucleotide probe libraries that recognize targets of interest. The targets include circulating biomarkers such as microvesicles, including those derived from various diseases.Type: ApplicationFiled: November 25, 2019Publication date: August 27, 2020Applicant: Caris Science, Inc.Inventors: Valeriy DOMENYUK, Adam STARK, Nianqing XIAO, Zhenyu ZHONG, Mark MIGLARESE, David SPETZLER
-
Publication number: 20200024669Abstract: Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for the disease, such as treatments that provide potential benefit or potential lack of benefit for the disease. Molecular profiling can include biomarkers for immune checkpoint therapy, including microsatellite instability, tumor mutational burden, mismatch repair, and expression of checkpoint proteins such as PD-L1.Type: ApplicationFiled: March 20, 2018Publication date: January 23, 2020Applicant: CARIS MPI, INC.Inventors: David SPETZLER, Nianqing XIAO
-
Publication number: 20190317099Abstract: Methods and compositions are provided for specific aptamers and aptamer pools that bind biomarkers of interest such as microvesicle surface antigens or functional fragments of microvesicle surface antigens. In various embodiments, aptamers of the invention are used in diagnostic, prognostic, or theranostic processes to screen a biological sample for the presence or levels of biomarkers such as microvesicles that are determined to provide a diagnostic, prognostic, or theranostic readout. The diagnosis, prognosis, or theranosis may be related to cancer or other diseases and disorders. The invention also provides methods and composition to facilitate aptamer library screening and aptamer detection methods.Type: ApplicationFiled: March 6, 2018Publication date: October 17, 2019Inventors: David Halbert, Valeriy Domenyuk, David Spetzler, Tassilo Hornung, Frank Schafer, Nianqing Xiao
-
Publication number: 20180268937Abstract: A method, apparatus, and computer program product for analyzing biological data with an application that provides a graphical user interface are disclosed. A method in accordance with the disclosure may include receiving patient data associated with various patient attributes, determining an interrelationship between any one of those attributes, performing a therapeutic regime analysis, and displaying at least one graphical user interface. The method may further include assisting in providing patient care based on the interrelationships displayed on the graphical user interface. Patient attributes may include biomarker status that corresponds with the expression, sequence, or other state, of various biomarkers. The method, apparatus, and computer program product are useful for analyzing molecular profiling data.Type: ApplicationFiled: September 24, 2016Publication date: September 20, 2018Inventors: David SPETZLER, Quanyuan HE, Nianqing XIAO
-
Patent number: 9958448Abstract: Methods and compositions are provided for specific aptamers and aptamer pools that bind biomarkers of interest such as microvesicle surface antigens or functional fragments of microvesicle surface antigens. In various embodiments, aptamers of the invention are used in diagnostic, prognostic, or theranostic processes to screen a biological sample for the presence or levels of biomarkers such as microvesicles that are determined to provide a diagnostic, prognostic, or theranostic readout. The diagnosis, prognosis, or theranosis may be related to cancer or other diseases and disorders. The invention also provides methods and composition to facilitate aptamer library screening and aptamer detection methods.Type: GrantFiled: October 23, 2013Date of Patent: May 1, 2018Assignee: Caris Life Sciences Switzerland Holdings GMBHInventors: David Halbert, Valeriy Domenyuk, David Spetzler, Tassilo Hornung, Frank Schafer, Nianqing Xiao
-
Publication number: 20180066262Abstract: Methods and compositions are provided for oligonucleotide probes and oligonucleotide probe libraries that recognize targets of interest. The targets include circulating biomarkers such as microvesicles, including those derived from various diseases.Type: ApplicationFiled: March 9, 2016Publication date: March 8, 2018Inventors: Valeriy DOMENYUK, Adam STARK, Nianqing XIAO, Zhenyu ZHONG, Mark MIGLARESE, David SPETZLER
-
Publication number: 20160319361Abstract: Methods and compositions are provided for oligonucleotides that bind target biomarkers and allow characterization of a phenotype. The target biomarkers may include microvesicle antigens, including microvesicles derived from various diseases. The characterization may comprise detection, diagnosis, prognosis, theranosis or other characterization of a disease or disorder.Type: ApplicationFiled: August 28, 2014Publication date: November 3, 2016Inventors: David SPETZLER, Valeriy DOMENYUK, Nianqing XIAO, Adam STARK, Zhenyu ZHONG
-
Publication number: 20160003835Abstract: Methods and compositions are provided for specific aptamers and aptamer pools that bind biomarkers of interest such as microvesicle surface antigens or functional fragments of microvesicle surface antigens. In various embodiments, aptamers of the invention are used in diagnostic, prognostic, or theranostic processes to screen a biological sample for the presence or levels of biomarkers such as microvesicles that are determined to provide a diagnostic, prognostic, or theranostic readout. The diagnosis, prognosis, or theranosis may be related to cancer or other diseases and disorders. The invention also provides methods and composition to facilitate aptamer library screening and aptamer detection methods.Type: ApplicationFiled: October 23, 2013Publication date: January 7, 2016Inventors: David HALBERT, Valeriy DOMENYUK, David SPETZLER, Tassilo HORNUNG, Frank SCHAFER, Nianqing XIAO
-
Publication number: 20120183953Abstract: The invention generally relates to methods for assembling sequence contigs. In certain embodiments, methods of the invention involve converting sequence contigs into maps, generating a plurality of single molecule restriction maps, aligning single molecule restriction maps to ends of the maps of the sequence contigs, thereby producing extended sequence contigs, and aligning extended sequence contigs.Type: ApplicationFiled: April 28, 2011Publication date: July 19, 2012Applicant: OpGen, Inc.Inventors: Nianqing XIAO, John K. HENKHAUS, Bin ZHU, Deacon SWEENEY, Thomas ANANTHARAMAN, Ryan PTASHKIN
-
Patent number: 6174875Abstract: The present invention provides a method of inhibiting oxidative-stress induced cell death in a cell comprising contacting the cell with a composition comprising a benzoquinoid ansamycin. The present invention further provides a method of reducing neurological injury resulting from cardiac arrest or stroke comprising administering to a patient a composition comprising a benzoquinoid ansamycin.Type: GrantFiled: April 1, 1999Date of Patent: January 16, 2001Assignee: University of PittsburghInventors: Donald B. DeFranco, Clifton W. Callaway, Christopher Lipinski, Nianqing Xiao